Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India
- PMID: 22870011
- PMCID: PMC3409916
- DOI: 10.4103/0974-1208.97791
Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India
Abstract
Objective: The aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (PCOS).
Setting: Infertility clinic in a tertiary care hospital.
Study design: A prospective cross-sectional study.
Materials and methods: All the women attending the infertility clinic categorized as polycystic ovary syndrome according to Rotterdam criteria (2003) during the study period were included in the study. The women with PCOS underwent screening for metabolic syndrome as defined by the modified American Heart Association/National Heart Lung Blood Institute (AHA/NHLBI) modified ATP 111 (2005) definition. A multivariate logistic regression analysis was applied and significant predictors identified for the prediction of metabolic syndrome.
Results: The overall prevalence of metabolic syndrome according to the modified AHA/NHLBI ATP III (2005) criteria was 37.5%. A total of 5.8 % cases were detected to have diabetes mellitus, 8.3% had impaired fasting glucose, and 11.7 % had an impaired glucose test. Dyslipidemia was present in 93.3% cases of PCOS. Among all the risk factors, age and waist hip ratio ≥0.85 were strongly associated with the presence of metabolic syndrome.
Conclusion: Infertile women with PCOS, particularly those with age ≥25 years or with central obesity (a waist hip ratio of ≥0.85), are at a higher risk of developing metabolic syndrome and should be offered screening tests.
Keywords: Metabolic syndrome; polycystic ovary syndrome; screening.
Conflict of interest statement
Similar articles
-
Prevalence of metabolic syndrome in women with polycystic ovary syndrome and the factors associated: A cross sectional study at a tertiary care center in Hyderabad, south-eastern India.Diabetes Metab Syndr. 2020 Jul-Aug;14(4):583-587. doi: 10.1016/j.dsx.2020.05.006. Epub 2020 May 11. Diabetes Metab Syndr. 2020. PMID: 32416528
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6. Hum Reprod. 2012. PMID: 22674204
-
Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.J Med Assoc Thai. 2010 Jun;93(6):653-60. J Med Assoc Thai. 2010. PMID: 20572369
-
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.J Clin Endocrinol Metab. 2010 May;95(5):2038-49. doi: 10.1210/jc.2009-2724. Epub 2010 Apr 7. J Clin Endocrinol Metab. 2010. PMID: 20375205 Review.
Cited by
-
An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India.Indian J Med Res. 2022 Sep;156(3):449-458. doi: 10.4103/ijmr.IJMR_2497_19. Indian J Med Res. 2022. PMID: 36588359 Free PMC article.
-
A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with poly cystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial.Front Nutr. 2022 Nov 29;9:1071515. doi: 10.3389/fnut.2022.1071515. eCollection 2022. Front Nutr. 2022. PMID: 36523331 Free PMC article.
-
Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study.Int J Reprod Biomed. 2022 Apr 21;20(3):161-168. doi: 10.18502/ijrm.v20i3.10707. eCollection 2022 Mar. Int J Reprod Biomed. 2022. PMID: 35642189 Free PMC article.
-
Metabolic Syndrome among Patients with Polycystic Ovarian Syndrome Presenting to a Tertiary Care Hospital: A Descriptive Cross-Sectional Study.JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):137-141. doi: 10.31729/jnma.7221. JNMA J Nepal Med Assoc. 2022. PMID: 35210633 Free PMC article.
-
Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome.touchREV Endocrinol. 2021 Apr;17(1):54-58. doi: 10.17925/EE.2021.17.1.54. Epub 2021 Apr 28. touchREV Endocrinol. 2021. PMID: 35118446 Free PMC article. Review.
References
-
- Frank S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–61. - PubMed
-
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800. - PubMed
-
- Legro RS. Polycystic ovary syndrome and cardiovascular disease: A premature association? Endocr Rev. 2003;24:302–12. - PubMed
-
- Korhonen S, Hippelainen M, Niskanen L, Vanhala M, Saarikoski S. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome; a controlled, population-based study. Am J Obstet Gynecol. 2001;184:289–96. - PubMed
-
- DeFronzo RA, Ferrannini E. Insulin resistance.A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94. - PubMed
LinkOut - more resources
Full Text Sources